2020 Webinar: Chronic Hepatitis C 500: The Advanced Course-Chronic Hepatitis C 500: The Advanced Course

Video Transcription

Video Summary

The webinar titled "Chronic Hepatitis C 500: The Advanced Course" features two presentations discussing important topics related to hepatitis C. The first presentation focuses on the risks and benefits of using hepatitis C-positive organs in transplantation. While this can expand the organ pool and help more patients, there are still risks involved, such as treatment failure and increased risk of rejection and infection. More research is needed to minimize these risks. The second presentation discusses the challenges of treating patients infected with rare genotypes of hepatitis C. These genotypes can be resistant to certain medications, leading to treatment failure. The use of triple combination therapies and further research is necessary to optimize treatment decisions for these patients. Overall, the use of direct-acting antiviral drugs has greatly improved treatment outcomes for hepatitis C, but there are still challenges in specific patient populations.

Asset Caption

Moderator: Omar Massoud, MD, PhD, FAASLD
Presenters: Brian L. Pearlman, MD, FAASLD, Preeti A. Reshamwala, MD and Jean-Michel Pawlotsky, MD, PhD, FAASLD

Keywords

Chronic Hepatitis C 500: The Advanced Course

hepatitis C-positive organs

transplantation

risks and benefits

treatment failure

rejection and infection risks

rare genotypes

medication resistance

triple combination therapies

treatment decisions

direct-acting antiviral drugs